Plus Therapeutics Inc Share Price Today: Live Updates & Key Insights
Plus Therapeutics Inc share price today is $0.24, up 2.82%. The stock opened at $0.2434 against the previous close of $0.2411, with an intraday high of $0.2528 and low of $0.23705.
Plus Therapeutics Inc Share Price Chart
Plus Therapeutics Inc
Plus Therapeutics Inc Share Price Performance
Plus Therapeutics Inc Institutional Holdings
Plus Therapeutics Inc Market Status
Plus Therapeutics Inc Fundamentals
Market Cap 44.22 M
PB Ratio 10.646
PE Ratio 0.0
Enterprise Value 34.75 M
Total Assets 16.33 M
Volume 4372954
Plus Therapeutics Inc Company Financials
About Plus Therapeutics Inc & investment objective
Company Information Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests comprising the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
Organisation Biotechnology
Employees 28
Industry Biotechnology
CEO Dr. Marc H. Hedrick M.B.A., M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Plus Therapeutics Inc FAQs
What is the share price of Plus Therapeutics Inc today?
The current share price of Plus Therapeutics Inc is $0.24.
Can I buy Plus Therapeutics Inc shares in India?
Yes, Indian investors can buy Plus Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Plus Therapeutics Inc shares in India?
You can easily invest in Plus Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Plus Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Plus Therapeutics Inc.
Can I buy fractional shares of Plus Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Plus Therapeutics Inc?
Plus Therapeutics Inc has a market cap of $44.22 M.
In which sector does Plus Therapeutics Inc belong?
Plus Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Plus Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Plus Therapeutics Inc?
The PE ratio of Plus Therapeutics Inc is N/A and the PB ratio is 10.65.